BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32773244)

  • 1. Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines.
    Forman R; Anderson M; Jit M; Mossialos E
    Vaccine; 2020 Sep; 38(39):6075-6077. PubMed ID: 32773244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keeping track of the SARS-CoV-2 vaccine pipeline.
    Parker EPK; Shrotri M; Kampmann B
    Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Jun; 16(696):1176-1177. PubMed ID: 32496711
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronavirus vaccines get a biotech boost.
    Dance A
    Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847
    [No Abstract]   [Full Text] [Related]  

  • 5. Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry.
    Coudeville L; Gomez GB; Jollivet O; Harris RC; Thommes E; Druelles S; Chit A; Chaves SS; Mahé C
    Vaccine; 2020 Nov; 38(48):7588-7595. PubMed ID: 33097312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. If a coronavirus vaccine arrives, can the world make enough?
    Khamsi R
    Nature; 2020 Apr; 580(7805):578-580. PubMed ID: 32273621
    [No Abstract]   [Full Text] [Related]  

  • 7. Ensuring global access to COVID-19 vaccines.
    Yamey G; Schäferhoff M; Hatchett R; Pate M; Zhao F; McDade KK
    Lancet; 2020 May; 395(10234):1405-1406. PubMed ID: 32243778
    [No Abstract]   [Full Text] [Related]  

  • 8. The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines.
    Kochhar S; Excler JL; Kim D; Robertson JS; Fast PE; Condit RC; Drew S; Wood D; Gurwith M; Klug B; Whelan M; Khuri-Bulos N; Mallett Moore T; Smith ER; Chen RT;
    Vaccine; 2020 Sep; 38(39):6184-6189. PubMed ID: 32747214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccine trials: Duty of care and standard of prevention considerations.
    Singh JA
    Vaccine; 2020 Nov; 38(48):7578-7580. PubMed ID: 33069443
    [No Abstract]   [Full Text] [Related]  

  • 10. Global governance for COVID-19 vaccines.
    The Lancet
    Lancet; 2020 Jun; 395(10241):1883. PubMed ID: 32563355
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 vaccines for all?
    Usher AD
    Lancet; 2020 Jun; 395(10240):1822-1823. PubMed ID: 32534638
    [No Abstract]   [Full Text] [Related]  

  • 12. Reporting COVID-19: A Conversation with Jon Cohen of Science.
    Dunavan CP
    Am J Trop Med Hyg; 2020 Oct; 103(4):1744-1747. PubMed ID: 32851970
    [No Abstract]   [Full Text] [Related]  

  • 13. Dozens to be deliberately infected with coronavirus in UK 'human challenge' trials.
    Callaway E
    Nature; 2020 Oct; 586(7831):651-652. PubMed ID: 33082550
    [No Abstract]   [Full Text] [Related]  

  • 14. The Race to Develop a COVID-19 Vaccine.
    Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and Bacillus Calmette-Guérin: What is the Link?
    Hegarty PK; Sfakianos JP; Giannarini G; DiNardo AR; Kamat AM
    Eur Urol Oncol; 2020 Jun; 3(3):259-261. PubMed ID: 32327396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 17. The COVID-19 vaccine development landscape.
    Thanh Le T; Andreadakis Z; Kumar A; Gómez Román R; Tollefsen S; Saville M; Mayhew S
    Nat Rev Drug Discov; 2020 May; 19(5):305-306. PubMed ID: 32273591
    [No Abstract]   [Full Text] [Related]  

  • 18. China's coronavirus vaccines are leaping ahead - but face challenges as virus wanes.
    Cyranoski D
    Nature; 2020 Aug; 584(7819):17-18. PubMed ID: 32737453
    [No Abstract]   [Full Text] [Related]  

  • 19. Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine.
    Pregelj L; Hine DC; Oyola-Lozada MG; Munro TP
    Trends Biotechnol; 2020 Sep; 38(9):943-947. PubMed ID: 32600777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19: Small-Molecule Clinical Trials Landscape.
    Ferreira LLG; Andricopulo AD
    Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.